Recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy NCT06427798 Conditions Gastrointestinal Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +8 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Not Yet Recruiting Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT) NCT07538791 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more Locations Policlinico di Bari — Bari, Italy IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy Azienda Ospedaliero-Universitaria di Ferrara — Ferrara, Italy Irst Irccs — Meldola, Italy View more locations Show fewer locations Loading locations... View Trial Details
Completed Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation NCT02186678 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more Locations Assistance Publique Hopitaux de Marseille — Marseille, France View Trial Details
Completed Stereotactic Body Radiotherapy for Spine Tumors NCT01347307 Conditions Arteriovenous Malformations, Benign Spinal Tumors, Cardiovascular Abnormalities, +31 more Locations Mercy Medical Center, St. Louis — St Louis, Missouri, United States View Trial Details
